[EN] SUBSTITUTED 4-PROLINE DERIVATIVES AS IGLUR ANTAGONISTS<br/>[FR] DÉRIVÉS SUBSTITUÉS DE 4-PROLINE EN TANT QU'ANTAGONISTES IGLUR
申请人:KØBENHAVNS UNI
公开号:WO2015003723A1
公开(公告)日:2015-01-15
The present invention relates to compounds of Formula (I), combinations and use thereof for disease therapy, or pharmaceutically acceptable salt or solvate thereof, including all tautomers, stereoismers and polymorphs thereof, which are iGluR receptor inhibitors, and hence are useful in the treatment of psychiatric diseases or neurological disorders or a disease or disorder associated with abnormal activities of iGluR receptors.
本发明涉及式(I)的化合物,以及这些化合物的组合物和用途,用于疾病治疗,或其药用盐或溶剂化合物,包括其所有互变异构体、立体异构体和多晶形式,这些化合物是iGluR受体抑制剂,因此在治疗精神疾病或神经系统疾病或与iGluR受体异常活动相关的疾病或疾病方面具有用处。